Glenmark Life Sciences inks CDMO supply deal with a Japanese pharma innovator
Glenmark Life Sciences will manufacture API in the therapeutic area of urinary anti-spasmodic, to supply to the global innovator
Glenmark Life Sciences will manufacture API in the therapeutic area of urinary anti-spasmodic, to supply to the global innovator
Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa
Sonoma will manufacture Ocudox by Avenova with packaging similar to NovaBay’s Avenova products
Shivalik Rasayan Limited have successfully submitted USMDF for API " Palbociclib " to USFDA
Varenicline Tablets (RLD Chantix) had estimated annual sales of US $412 million in the US
This agreement includes upfront and milestone payments with a combined potential value of over $500m and sales royalties.
Liraglutide belongs to the class of glucagon like peptide 1 receptor agonist (GLP?1 RA) drugs
10+ emerging markets, Japan & ANZ transition in final phase
The company makes its maiden entry into Azerbaijan’s pharmaceutical market
Submissions based on positive data from the Phase 3 BASIS trial, which were presented this past weekend at the American Society of Hematology (ASH) Annual Meeting
Subscribe To Our Newsletter & Stay Updated